The U.S. Food and Drug Administration has approved Elanco Animal Health's skin disease treatment for dogs, the health ...

Paris: Sanofi has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has ...

Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the ...

A mom is raising awareness by sharing pictures of her eleven-year-old daughter's eczema - which has caused pain, itching, and ...

Out of sight, out of mind” does not apply to Marc Leviste when it comes to Kris Aquino. Even if they have parted ways, the ...

The FDA announced earlier today that ilunocitinib tablets (Zenrelia; Elanco) has received its approval. The latest drug from ...

By Hector MacKenzie via SWNS A mom is raising awareness by sharing pictures of her eleven-year-old daughter's eczema - which ...

The canine atopic dermatitis treatment market is set to experience notable growth, with an expected increase from USD ...

Aurinia Pharma's LUPKYNIS is well-positioned to become a new standard of care. Read why I think AUPH stock is a strong buy.

Sanofi is pursuing several opportunities in MS, a debilitating nerve disease, to offset revenue losses after the recent end ...